| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/03/2009 | WO2009053733A3 Novel crystalline forms |
| 09/03/2009 | WO2009052075A3 Method of treating motor disorders with alpha-2b adrenergic receptor agonists |
| 09/03/2009 | WO2009049791A3 Radiolabeled nk3 receptor antagonist |
| 09/03/2009 | WO2009047633A3 Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate |
| 09/03/2009 | WO2009040754A3 Polymorphs of s-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,5h-benzo[i,j]quinolizine-2-carboxylic acid lysine salt |
| 09/03/2009 | WO2009030440A3 Sidna against hepatitis c virus (hcv) |
| 09/03/2009 | WO2009027823A9 Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application. |
| 09/03/2009 | WO2009021728A3 Targeted block copolymer micelles |
| 09/03/2009 | WO2009021121A3 Identification and characterization of hcv replicon variants with reduced susceptibility to a combination of polymerase and protease inhibitors, and methods related thereto |
| 09/03/2009 | WO2009020848A3 RNAI-RELATED INHIBITION OF TNFα SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA |
| 09/03/2009 | WO2009015981A3 Treatment of pediatric tumors |
| 09/03/2009 | WO2009011924A8 Use of a chemotherapeutic agent in the preparation of a medicament for treating or ameliorating an adverse side effect associated with oncolytic viral therapy |
| 09/03/2009 | WO2009003428A3 Substituted 6-anilinopurine derivatives as inhibitors of cytokinin oxidase/dehydrogenase and preparations containing these derivatives |
| 09/03/2009 | WO2009001219A3 Immunocytokines for cancer treatment in combination with chemotherapeutic agents |
| 09/03/2009 | WO2008133654A3 Method of treating a tumor and biodistribution of a drug delivered by worm-like filomicelles |
| 09/03/2009 | WO2008130296A9 Binding of pathological forms of proteins using conjugated polyelectrolytes |
| 09/03/2009 | WO2008068762A3 Chitosan formulation for cholesterol reduction in humans |
| 09/03/2009 | WO2008056356A3 Pyrimidine derivatives as posh and posh-ap inhibitors |
| 09/03/2009 | WO2006113204A3 Thymidine derivatives for treatmemt of kaposi's sarcoma |
| 09/03/2009 | US20090222955 Delta 6 desaturases from primulaceae, expressing plants and pufa-containing oils |
| 09/03/2009 | US20090222951 Biosynthesis of polyunsaturated fatty acids (PUFAs); use of transgenic organism modified with polypeptides having Delta-5 elongase or Delta 6-desaturase activity; production of unsaturated omega-3 fatty acids and triglycerides with an increased content of unsaturated fatty acids |
| 09/03/2009 | US20090221985 System for iontophoretic transdermal delivery of polymeric agents and methods of use thereof |
| 09/03/2009 | US20090221984 Method and apparatus for providing therapeutically effective dosage formulations of lidocaine with and without epinephrine |
| 09/03/2009 | US20090221841 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action |
| 09/03/2009 | US20090221821 Adenosine receptor antagonists and methods of making and using the same |
| 09/03/2009 | US20090221716 Composition Comprising At Least 3 Different Diols |
| 09/03/2009 | US20090221715 Novel polymorph of atovaquone |
| 09/03/2009 | US20090221714 Pharmaceutical Composition for Prevention and Treatment of Drug or Alcohol Addiction or Bipolar Disorder Using Sodium Phenylbutyrate |
| 09/03/2009 | US20090221713 Apoe mimetic agents |
| 09/03/2009 | US20090221712 Mandelic hydrazides |
| 09/03/2009 | US20090221711 Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors |
| 09/03/2009 | US20090221710 Acyclic Sulfamide Derivatives |
| 09/03/2009 | US20090221709 METHODS OF MODIFYING TASTE SENSATION IN AN ANIMAL USING COMPOUNDS THAT MODULATE T1R1/T1R3 Or T1R2/T1R3 RECEPTORS |
| 09/03/2009 | US20090221708 Medicinal preparation |
| 09/03/2009 | US20090221707 Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtained |
| 09/03/2009 | US20090221706 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 09/03/2009 | US20090221705 Omega 3 |
| 09/03/2009 | US20090221703 High penetration composition and uses thereof |
| 09/03/2009 | US20090221702 Compounds |
| 09/03/2009 | US20090221701 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure |
| 09/03/2009 | US20090221700 Carisprodol Articles and Methods |
| 09/03/2009 | US20090221699 Fab I Inhibitors |
| 09/03/2009 | US20090221698 Mannose derivatives for killing tumor cells |
| 09/03/2009 | US20090221697 Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase |
| 09/03/2009 | US20090221696 Flavonoid isolated from Pteridophyta, Thelypteris torresiana; anticancer |
| 09/03/2009 | US20090221695 Chroman Derivatives as Estrogenic Compounds |
| 09/03/2009 | US20090221694 Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone |
| 09/03/2009 | US20090221693 Novel use of organic compounds |
| 09/03/2009 | US20090221692 Cb2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antifibrogenic pathway in the liver |
| 09/03/2009 | US20090221691 Compositions and methods for inhibiting g protein signaling |
| 09/03/2009 | US20090221690 Pharmaceutical Composition for the Prevention/Treatment of Bone Disorders and a Process for the Preparation Thereof |
| 09/03/2009 | US20090221689 Macrocyclic Modulators of the Ghrelin Receptor |
| 09/03/2009 | US20090221688 Pharmaceutical compositions containing docetaxel and a degradation inhibitor and a process for obtaining the same |
| 09/03/2009 | US20090221687 Tetracyclic Monoamine Reuptake Inhibitors for Treatment of Cns Diseases and Disorders |
| 09/03/2009 | US20090221686 Modulation of the Transcription of Pro-Inflammatory Gene Products |
| 09/03/2009 | US20090221685 Oligomeric compounds and compositions for the use in modulation of micrornas |
| 09/03/2009 | US20090221684 Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof |
| 09/03/2009 | US20090221683 Combination of CXCR4 Antagonist and Morphogen to Increase Angiogenesis |
| 09/03/2009 | US20090221682 DNA Vaccine for Cancer Therapy |
| 09/03/2009 | US20090221681 Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer |
| 09/03/2009 | US20090221680 Aptamers that bind thrombin with high affinity |
| 09/03/2009 | US20090221679 Novel HIV Targets |
| 09/03/2009 | US20090221678 target heat shock protein (hsp) 27 in vivo; antisense oligonucleotide or RNAi nucleotide inhibitor with sequence specificity for hsp27 mRNA; injectable dosage unit form |
| 09/03/2009 | US20090221677 Methods for Reducing Body Fat and Increasing Lean Body Mass by Reducing Stearoyl-COA Desaturase 1 Activity |
| 09/03/2009 | US20090221676 Glucose-transport related genes, polypeptides, and methods of use thereof |
| 09/03/2009 | US20090221675 Use of iex-1 for the treatment of glioma tumors |
| 09/03/2009 | US20090221674 Compositions and methods for therapy and diagnosis of cancer |
| 09/03/2009 | US20090221672 Biomarker for Prostate Cancer |
| 09/03/2009 | US20090221671 Modulation of lmw-ptpase expression |
| 09/03/2009 | US20090221669 Disubstituted Aniline Compounds |
| 09/03/2009 | US20090221668 Synthesis and preparations of duloxetine salts |
| 09/03/2009 | US20090221667 Process for Annealing Amorphous Atorvastatin |
| 09/03/2009 | US20090221666 Stilbene derivatives and methods of inhibiting cancer cell growth and microbial growth |
| 09/03/2009 | US20090221665 Organic Compounds |
| 09/03/2009 | US20090221664 Pharmaceutical compositions of muscarinic receptor antagonists |
| 09/03/2009 | US20090221663 Pyrazole derivatives as 11-beta-hsd1 inhibitors |
| 09/03/2009 | US20090221661 Phosphodiesterase 4 inhibitors |
| 09/03/2009 | US20090221660 Novel crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid 471 |
| 09/03/2009 | US20090221659 Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea |
| 09/03/2009 | US20090221658 Pharmacological Treatment for Sleep Apnea |
| 09/03/2009 | US20090221657 Compounds, Compositions Containing Them, Preparation Thereof and Uses Thereof I |
| 09/03/2009 | US20090221656 Drug Combinations |
| 09/03/2009 | US20090221655 Antibacterial agents |
| 09/03/2009 | US20090221654 Prostaglandin e1 and e2 analogs for the treatment of various medical conditions |
| 09/03/2009 | US20090221653 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3H)-one-derivatives as beta2 adrenoreceptor agonists |
| 09/03/2009 | US20090221652 Combinations of metformin and meglitinide |
| 09/03/2009 | US20090221651 Chemical preconditioning as a preventative or treatment for excitotoxic synaptic damage |
| 09/03/2009 | US20090221650 Use of Pyridoxamine to Treat and/or Prevent Disease Processes |
| 09/03/2009 | US20090221649 Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines for the treatment of reperfusion injury and reperfusion damage |
| 09/03/2009 | US20090221648 Compositions for treatment of cognitive disorders |
| 09/03/2009 | US20090221647 N-(2-thiazolyl)-amide derivatives as gsk-3 inhibitors |
| 09/03/2009 | US20090221646 Crystalline solvate of omeprazole sodium |
| 09/03/2009 | US20090221645 Dihydroimidazothiazole Derivatives |
| 09/03/2009 | US20090221644 Gpcr Agonists |
| 09/03/2009 | US20090221643 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia |
| 09/03/2009 | US20090221642 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof-176 |
| 09/03/2009 | US20090221641 Diaza-spiro--nonane derivatives as neurokinin (nk1) antagonists |
| 09/03/2009 | US20090221640 Novel Crystal Modifications |
| 09/03/2009 | US20090221639 Heterocyclic GPCR Agonists |
| 09/03/2009 | US20090221638 Crystalline form of a biphenyl compound |